Making innovation come true
Innovation in healthcare goes beyond research and clinical validation: public procurement plays a crucial role in bringing new technologies into clinical practice. In this episode, Rossana Alessandrello explores how value-based procurement can shape the future of in silico medicine and healthcare innovation.
Innovation in healthcare does not end with research, regulation, or clinical validation. There is another critical step that often remains invisible: public procurement.
How do healthcare systems decide which technologies to adopt? How does innovation move from the lab into real clinical practice? And what role does value-based procurement play in the future of in silico medicine?
In this episode, we speak with Rossana Alessandrello, Value Based Procurement Director at AQuAS (Agència de Qualitat i Avaluació Sanitàries de Catalunya) and member of the VPH Board of Directors, about the complex pathway connecting innovation, healthcare systems, and patient impact.
A thoughtful conversation on one of the most important and least discussed aspects of healthcare innovation.
Related media
Episode 10- With great power comes great responsibility
In silico medicine is reshaping healthcare through computer models, but trust and equity are key. Collaboration among scientists, clinicians, patients, and policymakers ensures this digital future serves everyone.
Discover more
Episode 9: Beating childhood cancer with in silico medicine
Childhood cancer remains a global challenge. In the 9th Code and Cure video, we explore how in silico models simulate tumour responses to chemotherapy, helping doctors tailor safer, more effective treatments.
Discover more
Episode 8: Digital hearts – The future of cardiovascular medicine
Heart disease is the leading cause of death worldwide. In silico medicine lets clinicians virtually test pacemakers and occluders, optimising device choice and enhancing surgical precision.
Discover more